Diagnostic Kits/Paper: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
AClearwater (talk | contribs) |
||
| Line 16: | Line 16: | ||
=== Overview of IP Landscape === | === Overview of IP Landscape === | ||
==== Patent Protection ==== | |||
===== Bayh-Dole ===== | |||
==== Licensing ==== | |||
==== When IP Does and Does Not Work Effectively ==== | ==== When IP Does and Does Not Work Effectively ==== | ||
Revision as of 12:37, 3 December 2009
Are patents clogging the pipeline: The effects of intellectual property on commercialization and access to genetic diagnostics
(A Summary Paper of our Research to date)
By Carolina Rossini, Andrew Clearwater, and Mackenzie Cowell
Last Draft: December 3, 2009
Introduction
Description of the GDx Market
Defining Genetic Diagnostics
Brief History of GDx and Related Technology
- chemical patents at turn of century (see Palombi's work)
Overview of IP Landscape
Patent Protection
Bayh-Dole
Licensing
When IP Does and Does Not Work Effectively
Our Research Questions
Our Methodology
Forces affecting the GDx Industry
- Technical advances